JP2020533308A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020533308A5 JP2020533308A5 JP2020513753A JP2020513753A JP2020533308A5 JP 2020533308 A5 JP2020533308 A5 JP 2020533308A5 JP 2020513753 A JP2020513753 A JP 2020513753A JP 2020513753 A JP2020513753 A JP 2020513753A JP 2020533308 A5 JP2020533308 A5 JP 2020533308A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- composition
- compound
- substituted
- needed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 *N([C@](CC(c1cc(C(O*)=O)ccc1)O)O*)C(O*)=O Chemical compound *N([C@](CC(c1cc(C(O*)=O)ccc1)O)O*)C(O*)=O 0.000 description 5
- ZDUQJTVUWQHXBF-ARLHGKGLSA-N CC(C)C(C[C@H](c1nc(C(O)=O)c[s]1)OC(C)=O)N(C)C(OC(C)(C)C)=O Chemical compound CC(C)C(C[C@H](c1nc(C(O)=O)c[s]1)OC(C)=O)N(C)C(OC(C)(C)C)=O ZDUQJTVUWQHXBF-ARLHGKGLSA-N 0.000 description 1
- OZMJKQBMQWNYBS-VXGBXAGGSA-N CC(C)[C@@H](C[C@H](c1nc(C(O)=O)c[s]1)O)N(C)C(OC(C)(C)C)=O Chemical compound CC(C)[C@@H](C[C@H](c1nc(C(O)=O)c[s]1)O)N(C)C(OC(C)(C)C)=O OZMJKQBMQWNYBS-VXGBXAGGSA-N 0.000 description 1
- OZMJKQBMQWNYBS-RYUDHWBXSA-N CC(C)[C@H](C[C@@H](c1nc(C(O)=O)c[s]1)O)N(C)C(OC(C)(C)C)=O Chemical compound CC(C)[C@H](C[C@@H](c1nc(C(O)=O)c[s]1)O)N(C)C(OC(C)(C)C)=O OZMJKQBMQWNYBS-RYUDHWBXSA-N 0.000 description 1
- KACQRESHTOZOHT-HVEKOLDVSA-N CCOC(C1=CSC(C)([C@H](CC(C(C)C)N(C)C(OC(C)(C)C)=O)O)N1)=O Chemical compound CCOC(C1=CSC(C)([C@H](CC(C(C)C)N(C)C(OC(C)(C)C)=O)O)N1)=O KACQRESHTOZOHT-HVEKOLDVSA-N 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023022825A JP2023053386A (ja) | 2017-09-08 | 2023-02-16 | チューブリシンおよびそれらの中間体の調製のためのプロセス |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762556234P | 2017-09-08 | 2017-09-08 | |
| US62/556,234 | 2017-09-08 | ||
| PCT/US2018/050095 WO2019051322A1 (en) | 2017-09-08 | 2018-09-07 | PROCESS FOR THE PREPARATION OF TUBULYSINS AND INTERMEDIATES THEREOF |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023022825A Division JP2023053386A (ja) | 2017-09-08 | 2023-02-16 | チューブリシンおよびそれらの中間体の調製のためのプロセス |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020533308A JP2020533308A (ja) | 2020-11-19 |
| JP2020533308A5 true JP2020533308A5 (enExample) | 2021-10-14 |
Family
ID=63963374
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020513753A Ceased JP2020533308A (ja) | 2017-09-08 | 2018-09-07 | チューブリシンおよびそれらの中間体の調製のためのプロセス |
| JP2023022825A Pending JP2023053386A (ja) | 2017-09-08 | 2023-02-16 | チューブリシンおよびそれらの中間体の調製のためのプロセス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023022825A Pending JP2023053386A (ja) | 2017-09-08 | 2023-02-16 | チューブリシンおよびそれらの中間体の調製のためのプロセス |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US11389543B2 (enExample) |
| EP (1) | EP3679036A1 (enExample) |
| JP (2) | JP2020533308A (enExample) |
| KR (1) | KR20200051733A (enExample) |
| CN (1) | CN111601803A (enExample) |
| AU (1) | AU2018329951B2 (enExample) |
| BR (1) | BR112020004495A2 (enExample) |
| CA (1) | CA3073766A1 (enExample) |
| EA (1) | EA202090670A1 (enExample) |
| IL (1) | IL272837B2 (enExample) |
| MA (1) | MA50124A (enExample) |
| MX (1) | MX2020001928A (enExample) |
| SG (1) | SG11202001543XA (enExample) |
| TW (2) | TWI820038B (enExample) |
| WO (1) | WO2019051322A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA50124A (fr) * | 2017-09-08 | 2020-07-15 | Seattle Genetics Inc | Procédé de préparation de tubulysines et d'intermédiaires de celles-ci |
| KR20210073525A (ko) * | 2018-09-07 | 2021-06-18 | 씨젠 인크. | 튜불리신 및 이의 중간체의 제조를 위한 대체 방법들 |
| JP2024510435A (ja) | 2021-03-18 | 2024-03-07 | シージェン インコーポレイテッド | 生体活性化合物の内部移行複合体からの選択的薬物放出 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10230872A1 (de) | 2002-07-09 | 2004-01-22 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Verfahren zur Herstellung von substituierten Thiazol-2-ylmethylestern |
| ES2708763T3 (es) | 2005-07-07 | 2019-04-11 | Seattle Genetics Inc | Compuestos de monometilvalina que tienen modificaciones de la cadena lateral de fenilalanina en el extremo C |
| PT2032606E (pt) | 2006-05-30 | 2014-02-05 | Genentech Inc | Anticorpos e imunoconjugados e respetivas utilizações |
| CN109627287A (zh) | 2007-02-23 | 2019-04-16 | 爱勒让治疗公司 | 三唑大环系统 |
| US20100047841A1 (en) * | 2007-02-27 | 2010-02-25 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Synthesis of desacetoxytubulysin h and analogs thereof |
| CA2866612C (en) | 2012-03-08 | 2018-01-16 | Halozyme, Inc. | Conditionally active ph-dependent cetuximab variant anti-epidermal growth factor receptor antibodies and method of use thereof |
| CN104640572B (zh) | 2012-05-15 | 2018-04-27 | 索伦托医疗有限公司 | 药物偶联物，偶联方法，及其用途 |
| CN104822656B (zh) | 2012-05-15 | 2018-05-01 | 西雅图基因公司 | 自稳定接头偶联物 |
| EP2708243A1 (en) * | 2012-09-17 | 2014-03-19 | OntoChem GmbH | Receptor ligand linked cytotoxic molecules |
| PE20160715A1 (es) | 2013-05-31 | 2016-08-01 | Genentech Inc | Anticuerpos frente a acidos teicoicos de pared y conjugados |
| MX369758B (es) | 2013-05-31 | 2019-11-20 | Genentech Inc | Anticuerpos anti-acido teicoico de pared y conjugados. |
| HRP20241124T1 (hr) * | 2014-09-11 | 2024-11-22 | Seagen Inc. | Ciljana isporuka lijekovitih tvari koje sadrže tercijarni amin |
| CA2969689A1 (en) * | 2014-12-03 | 2016-06-09 | Genentech, Inc. | Quaternary amine compounds and antibody-drug conjugates thereof |
| KR20170137725A (ko) * | 2015-02-25 | 2017-12-13 | 윌리엄 마쉬 라이스 유니버시티 | 데스아세톡시투불리신 h 및 이의 유사체 |
| MA50124A (fr) * | 2017-09-08 | 2020-07-15 | Seattle Genetics Inc | Procédé de préparation de tubulysines et d'intermédiaires de celles-ci |
-
2018
- 2018-09-07 MA MA050124A patent/MA50124A/fr unknown
- 2018-09-07 WO PCT/US2018/050095 patent/WO2019051322A1/en not_active Ceased
- 2018-09-07 EP EP18792575.5A patent/EP3679036A1/en not_active Withdrawn
- 2018-09-07 AU AU2018329951A patent/AU2018329951B2/en not_active Ceased
- 2018-09-07 MX MX2020001928A patent/MX2020001928A/es unknown
- 2018-09-07 EA EA202090670A patent/EA202090670A1/ru unknown
- 2018-09-07 IL IL272837A patent/IL272837B2/en unknown
- 2018-09-07 BR BR112020004495-4A patent/BR112020004495A2/pt not_active Application Discontinuation
- 2018-09-07 TW TW107131484A patent/TWI820038B/zh not_active IP Right Cessation
- 2018-09-07 US US16/645,369 patent/US11389543B2/en active Active
- 2018-09-07 CN CN201880062053.2A patent/CN111601803A/zh active Pending
- 2018-09-07 SG SG11202001543XA patent/SG11202001543XA/en unknown
- 2018-09-07 JP JP2020513753A patent/JP2020533308A/ja not_active Ceased
- 2018-09-07 TW TW112136966A patent/TW202428569A/zh unknown
- 2018-09-07 KR KR1020207009940A patent/KR20200051733A/ko not_active Ceased
- 2018-09-07 CA CA3073766A patent/CA3073766A1/en active Pending
-
2022
- 2022-06-08 US US17/835,841 patent/US20220323601A1/en not_active Abandoned
-
2023
- 2023-02-16 JP JP2023022825A patent/JP2023053386A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2842123T3 (es) | Purificación de tenofovir alafenamida y sus intermedios | |
| SG11202112875UA (en) | Compounds for treatment of pd-l1 diseases | |
| US9676803B2 (en) | Efficient process for separation of diastereomers of 9-[(R)-2-[[(R,S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl]methoxy]propyl]adenine | |
| JP2017160262A (ja) | 抗ウイルス化合物の合成 | |
| JP2014509322A5 (enExample) | ||
| JP2018504437A5 (enExample) | ||
| JP2020534336A5 (enExample) | ||
| WO2016016766A2 (en) | A process for the preparation of isavuconazonium or its salt thereof | |
| EP3658549A1 (en) | Process for preparing and purifying the lfa-1 antagonist lifitegrast | |
| CN107735398A (zh) | 用于合成雷帕霉素衍生物的方法 | |
| AU2018371771A1 (en) | Solid state form of Valbenazine | |
| US10584100B2 (en) | Solid state forms of netarsudil mesylate | |
| JP2024530795A (ja) | ニロガセスタットの合成 | |
| EP3091007A1 (en) | Process for the preparation of piperidine compounds | |
| JP6851149B2 (ja) | ピペリジン化合物の製造方法 | |
| IL272837B1 (en) | A process for preparing tubolysins and their intermediates | |
| EP3003320A2 (en) | Novel polymorph of regadenoson | |
| WO2017118928A9 (en) | Process for the separation of diastereomers of tenofovir alafenamide | |
| JP2021536475A5 (enExample) | ||
| JPWO2021015109A5 (enExample) | ||
| JP2013520440A5 (enExample) | ||
| JP2024525792A5 (enExample) | ||
| JP6507976B2 (ja) | イミダゾール−２−カルボン酸エステル誘導体又はその塩の製造方法 | |
| JP2024516199A (ja) | バルベナジンの合成方法 | |
| US11905250B2 (en) | Methods for preparation of jasmonate compounds |